Immunophotonics
Immunophotonics | WORKING TOWARD A CANCER-FREE LIFE.
Launch date
Employees
Market cap
-
Enterprise valuation
€24—35m (Dealroom.co estimates Feb 2023.)
St. Louis Missouri (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $550k | Early VC | |
N/A | $100k | Early VC | |
N/A | $50.0k | Grant | |
N/A | Series A | ||
$1.8m | Series A | ||
$1.8m | Series A | ||
N/A | Early VC | ||
* | $2.4m | Grant | |
* | N/A | $6.5m | Early VC |
* | N/A | $4.0m | Debt |
Total Funding | €12.0m |
Related Content
Recent News about Immunophotonics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.